AU6586298A - Glucagon-like peptide-1 analogs - Google Patents
Glucagon-like peptide-1 analogsInfo
- Publication number
- AU6586298A AU6586298A AU65862/98A AU6586298A AU6586298A AU 6586298 A AU6586298 A AU 6586298A AU 65862/98 A AU65862/98 A AU 65862/98A AU 6586298 A AU6586298 A AU 6586298A AU 6586298 A AU6586298 A AU 6586298A
- Authority
- AU
- Australia
- Prior art keywords
- glucagon
- analogs
- peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/605—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4116797P | 1997-03-31 | 1997-03-31 | |
US60041167 | 1997-03-31 | ||
PCT/US1998/005945 WO1998043658A1 (en) | 1997-03-31 | 1998-03-25 | Glucagon-like peptide-1 analogs |
Publications (1)
Publication Number | Publication Date |
---|---|
AU6586298A true AU6586298A (en) | 1998-10-22 |
Family
ID=21915105
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU65862/98A Abandoned AU6586298A (en) | 1997-03-31 | 1998-03-25 | Glucagon-like peptide-1 analogs |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU6586298A (en) |
WO (1) | WO1998043658A1 (en) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2777283B1 (en) * | 1998-04-10 | 2000-11-24 | Adir | NOVEL GLUCAGON-PEPTIDE- 1 (7-37) ANALOGUE PEPTIDE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME |
US6284725B1 (en) | 1998-10-08 | 2001-09-04 | Bionebraska, Inc. | Metabolic intervention with GLP-1 to improve the function of ischemic and reperfused tissue |
US6429197B1 (en) * | 1998-10-08 | 2002-08-06 | Bionebraska, Inc. | Metabolic intervention with GLP-1 or its biologically active analogues to improve the function of the ischemic and reperfused brain |
US7259136B2 (en) | 1999-04-30 | 2007-08-21 | Amylin Pharmaceuticals, Inc. | Compositions and methods for treating peripheral vascular disease |
ES2302390T3 (en) * | 1998-12-07 | 2008-07-01 | Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. | GLP-1 ANALOGS |
US6514500B1 (en) | 1999-10-15 | 2003-02-04 | Conjuchem, Inc. | Long lasting synthetic glucagon like peptide {GLP-!} |
EA003922B1 (en) | 1999-05-17 | 2003-10-30 | Конджачем, Инк. | Long lasting insulinotropic peptides |
ATE309818T1 (en) | 2000-03-08 | 2005-12-15 | Novo Nordisk As | LOWERING SERUM CHOLESTEROL |
US6706689B2 (en) * | 2000-05-19 | 2004-03-16 | Amylin Pharmaceuticals, Inc. | Treatment of acute coronary syndrome with GLP-1 |
ATE416784T1 (en) | 2000-12-01 | 2008-12-15 | Takeda Pharmaceutical | METHOD FOR PRODUCING A PREPARATION WITH A BIOACTIVE SUBSTANCE |
HUE038395T2 (en) | 2003-11-20 | 2018-10-29 | Novo Nordisk As | Propylene glycol-containing peptide formulations which are optimal for production and for use in injection devices |
DE602004031455D1 (en) | 2003-12-09 | 2011-03-31 | Novo Nordisk As | REGULATION OF FOOD PREFERENCE WITH GLP-1 AGONISTS |
BRPI0506694A (en) | 2004-01-08 | 2007-05-02 | Theratechnologies Inc | Long-acting glucagon-like peptide-1 analogs |
CN1950078A (en) | 2004-06-11 | 2007-04-18 | 诺和诺德公司 | Counteracting drug-induced obesity using glp-1 agonists |
US8097586B2 (en) | 2005-01-14 | 2012-01-17 | Wuxi Grandchamp Pharmaceutical Technology Co., Ltd. | Modified exedins and uses thereof |
JP4945555B2 (en) | 2005-05-10 | 2012-06-06 | ラボラトワール フルニエ エス・アー | Novel use of liver X receptor agonist |
EP2007804B1 (en) | 2006-04-20 | 2014-06-18 | Amgen, Inc | Glp-1 compounds |
WO2008019147A2 (en) | 2006-08-04 | 2008-02-14 | Amylin Pharmaceuticals, Inc. | Use of exendins, exendin agonists and glp-1 receptor agonists for altering the concentration of fibrinogen |
EP2555791B1 (en) | 2010-04-09 | 2017-11-01 | Sinai Health System | Methods for treating disorders of the gastrointestinal tract using a glp-1 agonist |
JP6224586B2 (en) | 2012-07-10 | 2017-11-01 | 武田薬品工業株式会社 | Injectable preparation |
CA3082033A1 (en) | 2017-08-24 | 2019-02-28 | Novo Nordisk A\S | Glp-1 compositions and uses thereof |
PE20230819A1 (en) | 2020-02-18 | 2023-05-19 | Novo Nordisk As | COMPOSITIONS AND USES OF GLP-1 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5705483A (en) * | 1993-12-09 | 1998-01-06 | Eli Lilly And Company | Glucagon-like insulinotropic peptides, compositions and methods |
EP0879279A4 (en) * | 1996-02-06 | 2000-07-12 | Lilly Co Eli | Diabetes therapy |
-
1998
- 1998-03-25 WO PCT/US1998/005945 patent/WO1998043658A1/en active Search and Examination
- 1998-03-25 AU AU65862/98A patent/AU6586298A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1998043658A1 (en) | 1998-10-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL136377A0 (en) | Glucagon-like peptide-1 crystals | |
AU6586298A (en) | Glucagon-like peptide-1 analogs | |
AU1617399A (en) | Glp-1 formulations | |
HUP9903714A3 (en) | Glp-1 derivatives | |
AU2610599A (en) | N-terminally truncated glp-1 derivatives | |
ZA981343B (en) | Sulfonylurea-glitazone combinations for diabetes | |
AU2524995A (en) | Neurokinine (tachykinine) antagonists | |
AU9501798A (en) | Low work-function electrode | |
AU9036098A (en) | Parallel mechanism | |
AU1274099A (en) | Low work-function electrode | |
AU9552498A (en) | Phthalocyanine analogs | |
AU8747498A (en) | Food-preservative composition | |
AU9066598A (en) | Substituted 4-benzoyl-pyrazoles | |
AU8917398A (en) | Torch | |
AU5203698A (en) | Fluid-treatment assemblies | |
EP0903415A3 (en) | Structure expansée | |
AU8121998A (en) | Composition | |
AU2394697A (en) | Porcine retrovirus | |
AU5953598A (en) | Plaque-inhibiting composites | |
ZA984895B (en) | Solvent replacement | |
AU8072498A (en) | Heregulin-like factor | |
AU1098499A (en) | Emulsifier-lipid composition | |
AU6090898A (en) | Substituted 4-benzoyl-pyrazoles | |
ZA977791B (en) | GLP-1 derivatives. | |
ZA200304047B (en) | Analogues of GLP-1. |